Nutrition
Volume 26, Issue 7 , Pages 842-848 , July 2010

High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy

  • Kimberley Mellor, B.Sc.

      Affiliations

    • Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • Rebecca H. Ritchie, Ph.D.

      Affiliations

    • Heart Failure Pharmacology, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    • ,
  • Greta Meredith, B.Sc.

      Affiliations

    • Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia
    • ,
  • Owen L. Woodman, Ph.D.

      Affiliations

    • School of Medical Sciences, Royal Melbourne Institute of Technology, Melbourne, Victoria, Australia
    • ,
  • Margaret J. Morris, Ph.D.

      Affiliations

    • Department of Pharmacology, University of New South Wales, Sydney, New South Wales, Australia
    • ,
  • Lea M.D. Delbridge, Ph.D.

      Affiliations

    • Department of Physiology, University of Melbourne, Melbourne, Victoria, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-3-8344-5853; fax: +61-3-8344-5897.

Received 20 October 2008 ,Accepted 10 August 2009.

References 

  1. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev. 2005;63:133–157
  2. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512–516
  3. Daly M. Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr. 2003;78:865S–8672
  4. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005;2:5
  5. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation. 2003;107:1448–1453
  6. McGuinness OP, Cherrington AD. Effects of fructose on hepatic glucose metabolism. Curr Opin Clin Nutr Metab Care. 2003;6:441–448
  7. Mayes PA. Intermediary metabolism of fructose. Am J Clin Nutr. 1993;58:754S–7565
  8. Huggins CE, Domenighetti AA, Ritchie ME, Khalil N, Favaloro JM, Proietto J, et al. Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention. J Mol Cell Cardiol. 2008;44:270–280
  9. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448–454
  10. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008;51:93–102
  11. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689
  12. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, et al. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis. 2005;179:43–49
  13. Oda T, Hirata M, Oshida Y, Han YQ, Koshinaka K, Sato Y. Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats. Endocr J. 2004;51:69–74
  14. Farah V, Elased KM, Chen Y, Key MP, Cunha TS, Irigoyen MC, et al. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci. 2006;130:41–50
  15. Girard A, Madani S, El Boustani ES, Belleville J, Prost J. Changes in lipid metabolism and antioxidant defense status in spontaneously hypertensive rats and Wistar rats fed a diet enriched with fructose and saturated fatty acids. Nutrition. 2005;21:240–248
  16. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, et al. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism. 2006;55:478–488
  17. Kamide K, Rakugi H, Higaki J, Okamura A, Nagai M, Moriguchi K, et al. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens. 2002;15:66–71
  18. Reed MJ, Ho H, Donnelly R, Reaven GM. Salt-sensitive and carbohydrate-sensitive rodent hypertension: evidence of strain differences. Blood Press. 1994;3:197–201
  19. D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension. 2005;46:806–811
  20. Nyby MD, Abedi K, Smutko V, Eslami P, Tuck ML. Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats. Hypertens Res. 2007;30:451–457
  21. Iyer SN, Raizada MK, Katovich MJ. AT1 receptor density changes during development of hypertension in hyperinsulinemic rats. Clin Exp Hypertens. 1996;18:793–810
  22. Hsieh PS, Tai YH, Loh CH, Shih KC, Cheng WT, Chu CH. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats. Metabolism. 2005;54:157–164
  23. Chess DJ, Lei B, Hoit BD, Azimzadeh AM, Stanley WC. Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol. 2007;293:H1853–H1860
  24. Farah V, Elased KM, Morris M. Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high fructose diet. Am J Physiol Heart Circ Physiol. 2007;293:H1083–H1089
  25. Nyby MD, Matsumoto K, Yamamoto K, Abedi K, Eslami P, Hernandez G, et al. Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am J Hypertens. 2005;18:213–219
  26. Cai L, Wang J, Li Y, Sun X, Wang L, Zhou Z, et al. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy. Diabetes. 2005;54:1829–1837
  27. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24:816–823
  28. Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, Favaloro JM, et al. The antioxidant Tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol. 2007;42:1119–1128
  29. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol. 2004;286:H2408–H2415
  30. Munzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol. 2002;22:1761–1768
  31. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108
  32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408
  33. Busserolles J, Gueux E, Rock E, Demigne C, Mazur A, Rayssiguier Y. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats. J Nutr. 2003;133:1903–1908
  34. Choi JS, Song J. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition. 2009;25:676–685
  35. Bengtsson SH, Gulluyan LM, Dusting GJ, Drummond GR. Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology. Clin Exp Pharmacol Physiol. 2003;30:849–854
  36. Kobayashi R, Nagano M, Nakamura F, Higaki J, Fujioka Y, Ikegami H, et al. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension. 1993;21:1051–1055
  37. Togashi N, Ura N, Higashiura K, Murakami H, Shimamoto K. The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats. J Hypertens. 2000;18:1605–1610
  38. Di Verniero CA, Silberman EA, Mayer MA, Opezzo JA, Taira CA, Hocht C. In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats. J Cardiovasc Pharmacol. 2008;51:532–541
  39. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, et al. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 2005;146:5341–5349
  40. Ovide-Bordeaux S, Bescond-Jacquet A, Grynberg A. Cardiac mitochondrial alterations induced by insulin deficiency and hyperinsulinaemia in rats: targeting membrane homeostasis with trimetazidine. Clin Exp Pharmacol Physiol. 2005;32:1061–1070

 This study was supported by Diabetes Australia, the National Heart Foundation, and the National Health and Medical Research Council, Australia.

PII: S0899-9007(09)00342-6

doi: 10.1016/j.nut.2009.08.017

Nutrition
Volume 26, Issue 7 , Pages 842-848 , July 2010

Article Tools

* Image Usage & Resolution